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INTRODUCTION
During oogenesis, mouse oocytes enter the prophase of the first meiotic division and remain arrested at the dictyate stage of prophase I (secondarily decondensed diplotene chromosomes) or at the germinal vesicle (GV) stage. Shortly after birth, they undergo a period of extensive growth, and their diameter increases from about 20 to 80 m. They are transcriptionally and translationally active [1, 2] . Toward the end of this growth phase, when they reach about 80% of their full size, oocytes acquire meiotic competence, and they will spontaneously resume meiosis in vitro when released from their follicular environment [3] [4] [5] . Mouse oocytes have been classified as incompetent or competent according to their respective inability or ability to spontaneously resume meiosis in vitro. Acquisition of meiotic com-petence occurs in two steps: First, the oocytes become competent to undergo germinal vesicle breakdown (GVBD) and to assemble a metaphase I (MI) spindle with condensed chromosomes (G2-to MI-phase transition); and second, they later acquire the ability to progress until metaphase II (MII) [4, 6] . Isolation of the first wave of developing oocytes at various days following birth yields a relatively synchronous population [7] . Oocytes from 12-day-old mice are contained within preantral follicles, are in mid-growth phase, and are incompetent of meiotic resumption. Although little is known about the mechanisms involved, meiotic competence acquisition depends on follicular cells [8, 9] and on an intrinsic autonomous program of differentiation (internal clock) [10, 11] .
Meiotic maturation is controlled by the cytoplasmic Mphase or maturation promoting factor (MPF), the key regulator of both mitotic and meiotic cell cycles, and the mitogen-activated protein kinases (MAPKs), also known as extracellular signal-regulated kinases (ERK), which have been implicated in many signal transduction pathways. MPF is a complex of cyclin B and p34 cdc2 activated through the dephosphorylation of threonine 14 and tyrosine 15 residues of p34 cdc2 by Cdc25 phosphatase and phosphorylation of threonine 161 of p34 cdc2 by cyclin-dependent kinase (CDK)-activating kinase (CAK). MPF is maintained inactivated by the Wee1 kinase, Myt1 kinase, and inhibitors (CDKIs). Moreover, upstream kinases (Polo-like kinases) and phosphatases (protein phosphatase 2 [PP2A]) are also implicated in MPF regulation [12] [13] [14] [15] [16] [17] [18] . MAP kinases are serine/threonine kinases activated by phosphorylation of threonine and tyrosine residues that are activated by a wide variety of oncogenes and extracellular stimuli. MAPKs participate in the signaling cascade downstream of growth factor/cytokine receptors, Ras, Raf, and MAPK kinase (MEK). Activation of MAPKs is more complicated than a simple linear pathway, and evidence exists for multiple, temporally distinct pathways converging on MAP kinases that are differentially utilized by various stimuli and cell types. MEKdependent and MEK-independent pathways exist that regulate activation of MAPKs [19, 20] . In the oocyte system, MAPKs are activated through a pathway that is believed to involve the p39 mos kinase and probably MEK or through the Ras-Raf-MEK pathway [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . MEK is a dual-specificity kinase that phosphorylates MAP kinases on threonine and tyrosine residues in the catalytic domain [31, 32] . MAP kinases are inhibited by PP2A, a protein tyrosine phosphatase, and/or Tyr/Thr-protein phosphatases (CL100/3CH134/ MKP-1, MKP-3) [33] [34] [35] . Activated MAPKs may directly or indirectly regulate some proteins that control MPF activity, such as Cdc25 phosphatase, Wee1 kinase, Myt1 kinase, and CAK [36] [37] [38] [39] . MAPKs have thus been implicated in the cascade leading to MPF activation, but an alternative pathway, in which MAPKs are activated by MPF, has also been proposed [40, 41] . p42 MAPK (ERK2) and p44 MAPK (ERK1) proteins [42] [43] [44] [45] are activated during meiotic re-sumption of Xenopus [26, 46, 47] and mouse [48] [49] [50] [51] oocytes. We and others demonstrated that p34 cdc2 , in contrast to cyclin B, p42 MAPK , and p44 MAPK , is less abundant in incompetent than in competent mouse prophase I oocytes, and that meiotic competence acquisition correlates with the presence of high levels of p34 cdc2 protein [52] [53] [54] [55] .
The inhibition of serine/threonine phosphatases 1 and 2A by okadaic acid (OA) [56, 57] induces meiotic resumption of oocytes of many species, including both competent [48, 51, [58] [59] [60] [61] [62] [63] and incompetent [52-54, 60, 64-66] mouse oocytes. Incompetent oocytes that have been freshly picked up respond to OA with delayed and asynchronous kinetics of meiotic resumption (GVBD) [54, 60, 61, 65] ; however, if incompetent oocytes are first cultured for 2 days and then treated with OA, their response is increased as demonstrated first by the fast and synchronous kinetics of meiotic maturation (GVBD) and, second, by the high percentage of oocytes resuming meiosis [61, 65] . In both cases, incompetent oocytes are arrested near MI because chromosomes are not aligned on the metaphase plate and are slightly decondensed [54, [67] [68] [69] .
The aim of the present study was to determine: 1) the morphological (chromatin) and biochemical (p34 cdc2 , p42 MAPK , and p44 MAPK ) differences between freshly picked-up and 2-day-cultured incompetent oocytes and 2) the role of MPF and MAPKs in the fast kinetics of OA-induced meiotic resumption of 2-day-cultured incompetent oocytes. Taken together, our results indicate that the MEK-MAPK pathway is implicated in OA-induced meiotic resumption of incompetent mouse oocytes.
MATERIALS AND METHODS

Oocyte Collection and Culture
All procedures involving mice were conducted in accordance with Swiss Office Veterinaire Cantonal authorizations and regulations concerning the use and care of experimental animals.
Fully grown meiotically competent oocytes were harvested from the ovaries of 20-to 28-day-old randomly bred Swiss albino mice. The follicles were punctured with fine forceps in minimal essential medium (MEM) with Earles salts (Gibco BRL, Paisley, UK) [60, 67] . The medium was supplemented with 200 M phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX; Sigma Chemical Company, St. Louis, MO) to prevent the spontaneous resumption of meiosis [70] . Oocytes were freed of attached cumulus cells.
Growing, meiotically incompetent oocytes were harvested from ovaries of 12-day-old randomly bred Swiss albino mice. Ovaries were excised and then dissected in medium 199 (M199) with Earles salts (Gibco BRL) [67] . Oocytes were enzymatically dissociated from follicular cells in a medium containing 250 U/ml DNase I (Sigma), 3.5 U/ ml trypsin (Sigma), and 59 U/ml collagenase (Worthington, Freehold, NJ).
Oocytes were cultured in a drop of medium (20 oocytes/ 50 l) at 37ЊC in a humidified atmosphere of 5% CO 2 under mineral oil (Sigma).
Oocyte Treatment with Okadaic Acid, PD98059, or Cycloheximide Incompetent and competent oocytes were incubated in an OA-containing M199 medium (Gibco) at a final concentration of 1 M for 2 h, washed, and then transferred to a control medium. PD98059 (Calbiochem, San Diego, CA), an inhibitor of MEK, was directly dissolved from DMSO stock into M199 medium at a final concentration of 10, 50, or 100 M. This MEK inhibitor was present 1 h before (preincubation), during, and following OA treatment. Control incubation contained PD98059 alone. The maximum concentration of PD98059 did not affect cell viability and did not induced meiotic resumption.
Cycloheximide (Sigma), was directly dissolved into M199 medium at a final concentration of 100 g/ml. This protein synthesis inhibitor was present during the entire incubation time.
Western Immunoblotting
Oocytes were lysed in 10 l of lysis buffer [71] . The samples were subjected to 10%-12% long (Figs. 2 and 4B) or short (Fig. 4 , A, C, and D; Fig. 6 ) SDS-PAGE [72] . Proteins were transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA) in cold buffer (25 mM Tris, 192 mM glycine, 25% methanol, 0.025% SDS) using a Bio-Rad transfer apparatus. p34 cdc2 , p42 MAPK , p44 MAPK , phosphop44/p42 MAP kinase, and phospho-specific MEK1/2 were detected by probing the membranes with, respectively, a monoclonal anti-p34 cdc2 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA), a polyclonal anti-ERK2 (p42 MAPK ) antibody (Santa Cruz Biotechnology), a polyclonal anti-ERK1 (p44 MAPK ) antibody (Santa Cruz Biotechnology), a polyclonal anti-phospho-p44/p42 MAP kinase (ERK1/2) antibody (New England Biolabs, Beverly, MA), and a polyclonal anti-phospho-specific MEK1/2 antibody (New England Biolabs) using a Blotting Chemiluminescence Detection Kit (Amersham, Buckinghamshire, UK) according to the manufacturer's instructions. For reprobing, the blots were stripped of bound antibodies by washing in a stripping buffer [54] at 50ЊC for 30 min. Equal numbers of incompetent oocytes were subjected to immunoblotting.
Histone H1 and MAPK In Vitro Assays
Oocytes were washed and then lysed in homogenization buffer [51, 54] . The reaction was started by the addition of 10 l of a solution containing 10 mM MgCl 2 ; 20 M protein kinase inhibitor (PKI; Sigma); 0.2 mM ATP (Sigma); 20 g/ml each of pepstatin, chymostatin, and aprotinin; 40 g/ml leupeptin; 0.4 mM sodium-orthovanadate; 5 Ci [␥-32 P]ATP (Amersham); 10 g histone H1 (Boehringer Mannheim, Mannheim, Germany); and 10 g myelin basic protein (MBP; Sigma). Reactions were performed at 37ЊC for 20 min and stopped by boiling for 3 min after addition of 20 l of a twofold concentrated electrophoresis sample buffer [72] . The samples were subjected to 15% SDS-PAGE. The gels were stained with Coomassie brillant blue R250 (Fluka, Buchs, Switzerland) and dried on filter paper. The bands corresponding to histone H1 and MBP were excised from the dried gels. Radioactivity was measured by liquid scintillation counting.
Immunofluorescence Staining and Microscopy
Oocytes were fixed and extracted in a microtubule-stabilizing buffer [54, 60] diluted 1:20, washed again, incubated in 10 g/ml of Hoechst dye 33258 (Fluka) for DNA staining, and finally mounted in Mowiol [73] and viewed on a Leitz epifluorescence microscope [54, 60] .
Chromosome Preparation
The air-drying method for chromosome preparation was used [74] . Briefly, OA-induced incompetent oocytes at or near MI were soaked in a hypotonic 1% sodium citrate (Sigma) physiological solution Ringer (Sigma) for 10 min at room temperature. A microdrop of this solution together with the oocytes was placed on a grease-free glass slide. The oocytes were then fixed by expelling a few drops of acetic acid-ethanol 1:3 on the microdrop and then air-dried. Finally, the preparation was stained with 2% toluidine blue for a few minutes, washed under tap water, dried, and observed with a microscope with a ϫ100 objective. Immersion oil was applied directly onto the slide.
RESULTS
Effect of Culture on Meiotic Competence Acquisition of Incompetent Mouse Oocytes
Our aim was to elucidate whether the difference in the kinetics of meiotic resumption induced by OA between freshly picked up (26% GVBD by 24 h) and 2-day-cultured (94% GVBD by 4 h) incompetent oocytes is the result of a sequential change in the organization of nuclear chromatin and nucleolar-associated chromatin; or to the accumulation or activation of cell cycle proteins p34 cdc2 , p42 MAPK , and p44 MAPK associated with oogenesis progression and expression of meiotic competence; or both.
Our results show that GV chromatin of freshly pickedup incompetent oocytes correspond to the pattern of staining with Hoechst, known as stages I and II according to Mattson et al. [75] (Fig. 1A) , whereas that of 2-day-cultured incompetent oocytes correspond to stages III and IV (Fig.  1B) . In stages I-II, GV contains several chromatin foci associated with the nucleolar periphery, whereas in stages III-IV, GV exhibits a partial or total rim of chromatin staining at the nucleolar surface. In addition, in stages III-IV, GV exhibits a more reticular or fibrillar chromatin pattern throughout the nucleoplasm. The transition from stages I-II to III-IV during the culture shows that incompetent oocytes progress toward meiotic competence acquisition.
Because it was previously shown that p34 cdc2 , p42 MAPK , and p44 MAPK are implicated in meiotic resumption of mouse oocytes, we compared the amount of these cell cycle proteins in freshly picked-up and 2-day-cultured incompetent oocytes by Western immunoblotting. As shown in Figure 2, p34 cdc2 , p42 MAPK , and p44 MAPK were present in similar amounts in both conditions. In some immunoblots, p34 cdc2 was even present in a lesser amount following the 2 days in culture (data not shown). These proteins were not activated during the culture because p34 cdc2 is present in the three migrating bands ( Fig. 2A) and there is no upward shifts in migration of p42 MAPK and p44 MAPK from phosphorylation (Fig. 2B) . These results show that the difference in the kinetics of GVBD is neither the result of the accumulation or activation of p34 cdc2 , nor to MAPKs.
Partial Meiotic Resumption of Incompetent Oocytes by Okadaic Acid
Incompetent oocytes cultured for 2 days and then treated with OA resumed meiosis and underwent GVBD, but did not extrude the first polar body. We consequently analyzed the spindle and the chromosomes. They often assembled an elongated and multipolar spindle (Fig. 3A) and the chromosomes were dispersed throughout the spindle instead of being aligned on the metaphase plate (Fig. 3B) , as previously described by us [54, 60, 67] for OA-treated freshly picked-up incompetent oocytes or for p34 cdc2 and cyclin B1 mRNA microinjected-incompetent oocytes. They are thus blocked near or at MI. Because chromosomes seemed to be less condensed (longer), we analyzed them by the air-drying method. As shown in Figure 3C , chromosomes stained with toluidine blue are present as bivalents, but compared with chromosomes of competent OA-induced (1 M for 2 h) MI oocytes (Fig. 3D) , they are insufficiently condensed and present differences in the degree of condensation within the same oocyte, suggesting an arrest in pro-MI.
Premature Activation of the MEK-MAPK Pathway
Our aim was to elucidate whether OA-induced meiotic resumption of incompetent oocytes cultured for 2 days was mediated through the MPF or the MEK-MAPK pathway. We thus analyzed the activity of these proteins by in vitro kinase assays, Western immunoblotting, or both.
Incompetent oocytes were cultured for 2 days and then treated with OA (1 M for 2 h). Following OA treatment but before GVBD, histone H1 kinase was only marginally activated (mean of 1.5-fold, n ϭ 3), whereas MAPK was highly activated (mean of 8.5-fold, n ϭ 3; Fig. 4A ) in incompetent oocytes. Thereafter, histone H1 kinase activity increases slightly up to MI (data not shown). The histone H1 and MAPK assays were linear with respect to time (for up to 40 min) and number of MII-arrested oocytes analyzed (up to 20; data not shown). The activation of MAPK following OA treatment was confirmed by Western immunoblotting using polyclonal antibodies anti-ERK2, anti-ERK1, and anti-phospho-p44/p42 MAP kinase. Following OA treatment, p42 MAPK and p44 MAPK were phosphorylated and thus activated, as revealed by upward shifts in migration (Fig. 4B) or appearance of the bands (Fig. 4C) . MEK, the MAPK kinase, was also phosphorylated and thus activated, as detected by an anti-phospho-specific MEK1/2 (Fig. 4C) . MEK, p42 MAPK , and p44 MAPK were already slightly phosphorylated after 1 h of OA-treatment (data not shown). Figure 4D shows the presence of equal amounts of p42 and p44 MAPK , validating the differences observed for phosphorylated MAPK and MEK in control (C)-and OA-treated oocytes (Fig. 4C) .
Our results indicate that MEK and MAP kinases are activated before MPF in incompetent oocytes treated by OA following 2 days in culture.
Inhibition of MAPK Activation and Meiotic Resumption by PD98059
We used an inhibitor of MEK, PD98059, as a pharmacological tool to study the involvement of MAP kinases in the induction of meiotic resumption of incompetent oocytes treated by OA following 2 days in culture. We consequently treated incompetent oocytes cultured for 2 days with 100 M PD98059 for 1 h before, during, and following OA treatment. As expected, PD98059 inhibited meiotic resumption ( Fig. 5) and phosphorylation of p42 MAPK and p44 MAPK (Fig. 6) . Nevertheless, meiotic inhibition is transient and not fully reversible because a lesser proportion of oocytes resume meiosis (mean of 50% GVBD after 1 day; Fig. 5 ). Lower concentrations of PD98059 (10 and 50 M) resulted in a proportionally lower yield of meiotic inhibition (Fig. 5) . p42 MAPK and p44 MAPK phosphorylation and thus activation were inhibited, as revealed by Western immunoblotting using the anti-phospho-p44/p42 MAP kinase antibody (Fig. 6A) . The incompetent oocytes, which overcame the presence of the MEK inhibitor by resuming meiosis (GVBD) contained activated p42 MAPK and p44 MAPK (data not shown). MEK appeared phosphorylated in the presence of PD98059, as detected by a polyclonal antibody anti-phospho-specific MEK1/2 (Fig. 6A) . Detection of total p42 MAPK and p44 MAPK proteins were used as a control in equal amounts in all conditions (Fig. 6B) . We also tested the effect of cycloheximide (100 g/ml) on OA-induced meiotic resumption of 2-day cultured incompetent oocytes because activation of MAP kinases required protein synthesis. No oocytes underwent GVBD (0%) for up to 1 day (data not shown), indirectly confirming the implication of MAP kinases in OA-induced meiotic resumption.
Together, our results indicate that OA induces meiotic resumption of incompetent oocytes through the precocious activation of the MEK-MAPK pathway.
DISCUSSION
We and others previously showed that the acquisition of meiotic competence at the end of oocyte growth appears to be associated with 1) the translational activation of dormant p34 cdc2 mRNA, resulting in an abrupt increase in the concentration of p34 cdc2 protein; and 2) the post-translational modification of cyclin B1 [52, 54, 55, 67] . The MAPK pathway is also implicated in meiotic competence acquisition [53, 54, [65] [66] [67] ; however, the implication of the MAPK pathway in the induction of meiosis in incompetent mouse oocytes has not been fully investigated.
The fast and synchronous meiotic resumption of oocytes cultured for 2 days before OA treatment could be explained by one or a combination of three factors. First, the reorganization of chromatin, indicating the progression of oocytes toward meiotic competence acquisition; second, the accumulation of p34 cdc2 and activation of MPF; and third, the activation of the MAPK pathway. We thus investigated these possibilities.
We observed the reorganization of chromatin (nucleolar riming) in the GV of oocytes cultured for 2 days. Incompetent oocytes thus progressed from stages I-II to III-IV as described by Mattson et al. [75] , showing that cultured incompetent oocytes progressed toward meiotic competence acquisition. Indeed, it is known that this sequential alteration in chromatin organization occurs before meiotic competence acquisition [75] [76] [77] . Nevertheless, incompetent oocytes cultured for 2 days did not acquire the capacity of spontaneous meiotic resumption.
Our results showed that p34 cdc2 , which is present in low levels in incompetent, freshly picked-up oocytes [54] , does not accumulate during the 2 days of culture. This finding is different from that of Chesnel and Eppig [52] who showed that the total amount of p34 cdc2 of incompetent oocytes increased during culture. They observed a threefold increase of p34 cdc2 , an amount still lower than that in competent oocytes. This discrepancy may be explained by the age of mice used to pick up oocytes (15-instead of 12-day-old females) and by the number of days incompetent oocytes have been cultured (3 days instead of 2). However, incompetent oocytes did not spontaneously resume meiosis. Our results and those of Chesnel and Eppig [66] showed that p42 MAPK and p44 MAPK did not accumulate and are not activated during the culture period.
We showed that incompetent oocytes cultured for 2 days and then treated with OA resume meiosis with premature MAPK activation, thus confirming the results of Chesnel and Eppig [66] . Indeed, MAP kinases are activated before GVBD, whereas histone H1 kinase is not activated. Our results showed that MEK is present in incompetent mouse oocytes, phosphorylated, and thus activated following OA treatment.
Activation of the MAPK pathway without MPF has been previously described in competent mouse, rat, and Xenopus oocytes. OA treatment of competent mouse oocytes blocked in prophase I (GV stage) by IBMX induces GVBD and MI entry with premature MAPK activation (before GVBD) in the absence of histone H1 kinase activation [51] . MAPK can also be activated in competent mouse oocytes blocked in prophase I by IBMX by injecting either Mos or MEK mRNA. Meiosis I is then significantly prolonged, and MAPK becomes fully activated in the absence of MPF [78] . In Xenopus oocyte extracts, constitutively active Mos also induced activation of MAPK without MPF [22] . Chesnel et al. [30] explained the incapacity of Xenopus stage-IV oocytes to activate MPF in response to insulin primarily by their inability to activate Ras and to stimulate Mos synthesis and, secondarily, by a deficiency in the mitogenic pathway that connects MAPK to MPF activation. Indeed, in contrast to mouse incompetent oocytes, injection of constitutively active Raf mRNA or Ras protein in incompetent Xenopus stage-IV oocytes resulted in activation of MAPK without inducing GVBD, suggesting that the Ras-Raf-MEK-MAPK cascade was functional, but that MAPK activation alone was not sufficient for meiotic resumption [30] . In rat oocytes, OA induces only partial MPF activa-tion, whereas activation of MAPK was accelerated and began 1 h after GVBD; therefore, 2 h earlier than in control oocytes [79] .
In order to confirm the implication of the MAPK pathway in meiotic resumption of incompetent oocytes cultured for 2 days and then treated with OA, we used an inhibitor of MEK, PD98059. PD98059 selectively blocks the activity of MEK by inhibiting the activation of MAPK and subsequent phosphorylation of MAPK substrates both in vitro and in intact cells [80] [81] [82] [83] . Our results showed that this inhibitor prevented activation of MAPKs (p42 MAPK and p44 MAPK ) and meiotic resumption (GVBD). Exposure of incompetent oocytes to PD98059 did not affect the overall contents of MAPKs but resulted in a loss of the dually phosphorylated forms of MAPKs, corresponding to active p42 MAPK and p44 MAPK . Nevertheless, meiotic inhibition is transient and not fully reversible because a lesser proportion of oocytes finally resume meiosis. This transient effect may be the result of the presence of both OA and MEK inhibitor acting on the same target, MEK. OA may overcome the effect of the MEK inhibitor by activating MEK through the inhibition of PP2A [84] .
In our system, following OA treatment, MEK is phosphorylated in the presence of the MEK inhibitor, PD98059, as detected by a polyclonal antibody anti-phospho-specific MEK1/2. It has been demonstrated that PD98059, a reversible inhibitor of MEK, prevents the activation and phosphorylation of MEK by Raf or MEK kinase in vitro and in vivo [80, 81] . The fact that in our conditions MEK is phosphorylated may be due to the partial reversibility of the inhibition of meiosis induced by PD98059, the timedependent antagonist effect of OA and PD98059 on the same target, MEK, or both. In Chaetopterus oocytes, exposure to PD98059 inhibited phosphorylation of MAPKs, but in contrast to mouse oocytes, it did not block GVBD [85] . In Xenopus oocytes, the microinjection of an inhibitory synthetic unphosphorylated MAPK peptide or the exposure to PD98059 blocked the activity of MAPK and prevented the progesterone-induced oocyte maturation. As for mouse oocytes, PD98059 failed to completely prevent the activation of MAPK and meiotic maturation of oocytes [86, 87] ; these researchers suggested that a little residual activation of MEK induced by progesterone in the oocytes treated with MEK inhibitors may, in the long run, bring about the activation of MAPK. On the other hand, in Swiss 3T3 cells, PD98059 inhibited the activation of MAPK, but the extent of inhibition depended on how potently Raf and MEK were activated by any particular agonist [80] .
Taken together, these results show that depending on the experimental system and conditions, activation of MAP kinases may or may not be sufficient to induce GVBD, and that activation of MAPKs and p34 cdc2 can occur on independent, parallel pathways, or on the same pathway. It is suggested that imbalanced coordination between protein kinases and protein phosphatases determines the cellular responses. Our results suggest that incompetent oocytes cultured for 2 days and then treated with OA, an inhibitor of phosphatases 1 and 2A, resume meiosis with fast kinetics of GVBD through the MEK-MAPK pathway.
